View in EDS

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

Saved in:
Bibliographic Details
Title: Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Authors: Licitra, L.1, Mesia, R.2, Rivera, F.3, Remenár, É.4, Hitt, R.5, Erfán, J.6, Rottey, S.7, Kawecki, A.8, Zabolotnyy, D.9, Benasso, M.10, Störkel, S.11, Senger, S.12, Stroh, C.13, Vermorken, J. B.14
Source: Annals of Oncology. May2011, Vol. 22 Issue 5, p1078-1087. 10p. 1 Color Photograph, 4 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdq588